![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 03, 2011 10:55:00 AM
The Company recognizes the difficulty for a new product to secure prominent shelf space
in drugstores. Its strategy will, therefore, depend on vigorous sales promotion and highly
visible point-of-purchase displays at high-traffic consumer corridors. The company feels
that the product is so superior to all other OTC pain relievers, that once tried with free
samples, the public will demand the product. Also, local-media coupons and direct
marketing will be creatively deployed by the Company to get its products distributed.
The Company will also attempt to make a strategic alliance with a major pharmaceutical
manufacturer and/or a pharmaceutical distribution company...<<<<< do you think this might raise the capital!
NADENDLA
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM